Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 8 of 8 entries
View as:

Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders

Phase: N/A Priority: Normal
NCT ID: NCT04322734 Org: User:
Start: 12/13/23 End: 12/31/28 Due: 12/31/29

In-Person Mindfulness-based Intervention for Adolescents with Autism Spectrum Disorder and Their Caregivers

Phase: N/A Priority: Normal
NCT ID: NCT06577623 Org: User:
Start: 08/14/24 End: 12/31/26 Due: 12/31/27

Investigating a Marijuana-based Compound as a Treatment for Anxiety in Autistic Adults

Phase: N/A Priority: Normal
NCT ID: NCT06526208 Org: User:
Start: 10/01/24 End: 09/30/27 Due: 09/30/28

Strengthening Skills Behavioral Intervention for Adults With Autism Spectrum Disorder

Phase: N/A Priority: Normal
NCT ID: NCT04802434 Org: User:
Start: 04/01/21 End: 04/30/23 Due: 04/30/24

Mindfulness-Based Intervention for Teens With Autism Spectrum Disorder and Their Caregivers

Phase: N/A Priority: Normal
NCT ID: NCT05685589 Org: User:
Start: 01/04/23 End: 04/08/24 Due: 04/08/25

Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum Disorder

Phase: N/A Priority: Normal
NCT ID: NCT02839915 Org: User:
Start: 08/13/20 End: 12/31/25 Due: 12/31/26

Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin Calcium

Phase: N/A Priority: Normal
NCT ID: NCT04060017 Org: User:
Start: 09/22/20 End: 06/30/26 Due: 06/30/27

Treatment of Social and Language Deficits With Leucovorin for Young Children With Autism

Phase: N/A Priority: Normal
NCT ID: NCT04060030 Org: User:
Start: 10/08/20 End: 06/30/26 Due: 06/30/27